Entries by

Embera NeuroTherapeutics Receives $11M Grant from National Institute on Drug Abuse for the Clinical Development of EMB-001 for the treatment of Cocaine Addiction

Embera NeuroTherapeutics, Inc., a specialty pharmaceutical company developing novel treatments for cocaine, nicotine, and other addictions, today announced that it has received an $11.1 million, three-year grant from the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH). The grant will support continued clinical development of EMB-001 for the treatment of cocaine addiction, which is clinically termed “cocaine use disorder.”

Embera NeuroTherapeutics Receives $11M Grant from National Institute on Drug Abuse for the Clinical Development of EMB-001 for the treatment of Cocaine Addiction

Embera NeuroTherapeutics, Inc., a specialty pharmaceutical company developing novel treatments for cocaine, nicotine, and other addictions, today announced that it has received an $11.1 million, three-year grant from the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH). The grant will support continued clinical development of EMB-001 for the treatment of cocaine addiction, which is clinically termed “cocaine use disorder.”

What is Cocaine

National Institute on Drug Abuse – Cocaine is a powerfully addictive stimulant drug. For thousands of years, people in South America have chewed and ingested coca leaves (Erythroxylon coca), the source of cocaine, for their stimulant effects.

Children & Teens

National Institute on Drug Abuse – Get the inside information on how different drugs can affect the brain and the body and what you can do to get involved.